The Corporate Forum presents IsoRay in Boston
The Corporate Forum is delighted to present IsoRay to a retail investor audience in Boston.
IsoRay, Inc. (NYSE MKT: ISR) is a medical technology company and is the exclusive manufacturer of Cesium-131. Cesium-131 allows for the internal radiation treatment of many different cancers because of its unique combination of high energy (its distinctive tissue penetrating capability reaching just far enough to treat the cancer) and its 9.7 day half-life (its matchless speed in giving off therapeutic radiation).
On May 22 the company announced "IsoRay’s GliaSite Approved for Sale in 31 European Countries; Significant Growth Expected as CE Mark Designation Clears the Way For International Launch"